Purchase Description.pdf
PDF 182 KB Posted
- Attached to
- Long Read Sequencing Kits
- Solicitation number
- 75N95025Q00095
About this file
This is a Purchase Description file for a solicitation seeking PromethION Flow Cell sequencing kits for the Center for Alzheimer's Disease and Related Dementias. The requirement is for a base quantity of 25 PromethION Flow Cells (v10.4.1, FLO-PRO114M) with two option quantities of 25 cells each, for a total potential quantity of 75 flow cells.
The flow cells must be capable of generating up to 290 Gb for sequencing DNA, cDNA or native RNA in real-time, be compatible with Nanopore PromethION 48 sequencers, contain Application-Specific Integrated Circuit (ASIC) for process control, and include recyclable electrical components. Delivery is F.O.B. destination to the National Institute on Aging in Bethesda, MD. The base delivery is due by September 30, 2025, with option deliveries due September 30, 2026 and September 30, 2027. The purpose is to support research identifying causative genes for neurodegenerative diseases through long-read sequencing analysis of biomarkers.
View the file
Other files
| File | Type | Posted |
|---|---|---|
| FAR 52.212-5 (Jan 2025).pdf | ||
| J-FAR 52.204-26 (Oct 2020).pdf | ||
| Invoicing Instructions.pdf | ||
| J-FAR 52.204-24 (Nov 2021).pdf |
On GovTribe
Work with this file
- Download the original file
- Contacts named in this file
- Similar government files
- Ask GovTribe AI about this file
Text version
Version 11-30-2016-1 FAR Part 11—Describing Agency Needs
PURCHASE DESCRIPTION
1. Statement of Need and Purpose: The purpose of this acquisition is to provide supplies to the Center for Alzheimer’s Disease and Related Dementias for neurodegenerative disease research for the purpose of long-read sequencing on Oxford Nanopore manufactured sequencing systems. These reagents will be used to identify causative genes for neurodegenerative diseases.
2. Background Information and Objective:
Biomarkers play a critical role in understanding, diagnosing, and monitoring disease progression and therapeutic efficacy. We aim to perform long read sequencing to analyze several biomarkers that will provide information about underlying molecular changes associated with AD/ADRD in well characterized samples from patients.
3. Generic Name of Product: Long Read Sequencing kits
Purchase Description:
Base Award: PromethION Flow Cells, v10.4.1, FLO-PRO114M, Qty 25 Option Line 1: PromethION Flow Cells, v10.4.1, FLO-PRO114M, Qty 25 Option Line 2: PromethION Flow Cells, v10.4.1, FLO-PRO114M, Qty 25
4. Salient characteristics All deliverables required under this contract shall be packaged, marked and shipped in accordance with Government specifications. At a minimum, all deliverables shall be marked with the contract number and Contractor name. The Contractor shall guarantee that all required materials shall be delivered in immediate usable and acceptable condition.
Vendor must provide these salient characteristics:
The flow cell must be able to generate up to 290 Gb for sequencing DNA, cDNA or native RNA in real-time.
The flow cell must be compatible with Nanopore PromethION 48 sequencers in form, fit, and function
The flow cell must contain Application-Specific Integrated Circuit (ASIC) to control and measure sequencing process
The flow cell must contain recyclable electrical components.
5. Delivery: Delivery shall be f.o.b. destination. Delivery shall be made to the National Institute on Aging located at 9000 Rockville Pike, Bethesda, MD 20892. The anticipated
Version 11-30-2016-1 FAR Part 11—Describing Agency Needs delivery dates are shown below.
Description Catalog No.
Delivery Date Estimated Delivery Date
9/30/2025 9/30/2026 9/30/2027
Quantity Optional
QTY1
Optional
QTY2
PromethION Flow Cells, v10.4.1 FLO-PRO114M 25 25 25
File details come from the government source that posted it. Updated .